title: Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience.
authors.affiliation: Department of Bone Marrow Transplantation and Hematology/Oncology, Idar-Oberstein, Germany.
authors.forename: N
authors.initials: N
authors.lastname: Basara
authors.forename: M G
authors.initials: MG
authors.lastname: Kiehl
authors.forename: W
authors.initials: W
authors.lastname: Blau
authors.forename: E
authors.initials: E
authors.lastname: Römer
authors.forename: M
authors.initials: M
authors.lastname: Bischoff
authors.forename: B
authors.initials: B
authors.lastname: Schmetzer
authors.forename: D
authors.initials: D
authors.lastname: Kirsten
authors.forename: S
authors.initials: S
authors.lastname: Günzelmann
authors.forename: A A
authors.initials: AA
authors.lastname: Fauser
mesh_terms: D000208:Acute Disease; D000328:Adult; D016026:Bone Marrow Transplantation / Q000276:immunology*; D002908:Chronic Disease; D016572:Cyclosporine / Q000627:therapeutic use; D005260:Female; D006086:Graft vs Host Disease / Q000188:drug therapy* / Q000517:prevention & control; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006650:Histocompatibility Testing; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007938:Leukemia / Q000401:mortality / Q000628:therapy*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use*; D009679:Nuclear Family; D012008:Recurrence; D012189:Retrospective Studies; D015996:Survival Rate; D014916:Whole-Body Irradiation
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid; D008727:Methotrexate